FTC monitoring how Big Pharma reacts to upcoming patent cliffs, official says
Source: SeekingAlpha
2026-03-18 07:39:09 ET
More on Pfizer, Merck, etc.
- Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation
- Eli Lilly Reaching For Peak GLP-1 Euphoria: Rotten Trading Momentum Since November
- Eli Lilly: The Weight-Loss Craze Isn't Over
- Lilly cut to Sell equivalent rating at HSBC on valuation concerns
- Pfizer succeeds in mid-stage trial for breast cancer therapy
Read the full article on Seeking Alpha
For further details see:
FTC monitoring how Big Pharma reacts to upcoming patent cliffs, official says
Roche Holding Ltd ADR
NASDAQ: RHHBY
RHHBY Trading
-0.24% G/L:
$49.23 Last:
583,766 Volume:
$48.91 Open:
RHHBY Latest News
March 24, 2026 02:00:00 am
Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets
RHHBY Stock Data
$361,973,933,704
6,306,832,002
N/A
43
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
